Neudle.com: dystonia parkinsonism

Differential
(Click to cross reference)

aciduria

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome-related complex

adolescent medicine

advances in neurology

adverse drug reaction

agitation

akathisia

akinesia of eyelid function

alcohol

algorithm

alien hand syndrome

alternating hemiplegia

alternating hemiplegia of childhood

anti basal ganglia antibodies

anti IgLON5

anticholinergic drugs

aphasia

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

attention deficit disorder with hyperactivity

atypical

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autonomic dysfunction

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

bent spine syndrome

beta adrenergic blocker

calcification, intracranial

calcium antagonist

calcium antagonist, side effects of

calculations

camptocormia

carbamazepine

carbon monoxide poisoning

CAT scan

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, isodense lesion with acute hemorrhage

CAT scan, muscle

catecholamine

central hypoventilation

central nervous system, infection of

cerebral cortical atrophy

cerebral ischemia

cerebral palsy

cerebral vasculature, calcification

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular accident, complications with

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

comprehension, impaired

compression fracture

conjugate gaze, forced

consanguinity

contractures, joint

convergence, impaired

conversion reaction

copper metabolism, abnormal

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

crying, pathologic

cultured skin fibroblasts

cyanide poison

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diagnostic criteria

differential diagnosis

diplopia

disability, neurological

diurnal variation

dopa responsive dystonia

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, causes of

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, axial

dystonia, cervical

dystonia, children

dystonia, classification

dystonia, delayed onset

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, psychogenic

dystonia, treatment of

dystonic reaction, acute

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, viral

encephalopathy

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

equinovarus

exercise

exercise-induced neurologic dysfunction

extrapyramidal

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

Fahr disease

falling

familial

fine motor function, impaired

flunarizine

fluoxetine

foot deformity

frontal behavioral spatial syndrome

frontal lobe, atrophy

gait disorder

gait, apraxic

galactorrhea

gamma amino butyric acid

gangliosidosis GM1

gaze palsy

gaze palsy, supranuclear

genetic diagnosis, prenatal

genetic neurologic disorders

genetic testing

gests antagoniste

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

grasp reflex

grimacing

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination, visual

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatosplenomegaly

heralding manifestation

HLA

hoarseness

homovanillic acid

human immunodeficiency virus type 1

iatrogenic neurologic disorders

inborn errors of metabolism

inclusion bodies, intranuclear

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

jaw jerk, abnormal

Kayser-Fleischer ring

kyphosis

language disorder in adults

laughing, pathologic

L-dopa

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

Lewy body disease, diffuse

lipid storage disorder of CNS

manganese intoxication

masked facies

medical-legal aspects of neurology

memory, defect of recent

memory, impairment of

meningitis

meningitis, carcinomatous

mental status, abnormal

metabolic disorder, primary

mitochondrial disease

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI

MRI pattern

MRI, abnormal

MRI, CAT scan compared to

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, mouse ears

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis

multiple system atrophy

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurochemistry

neurodegeneration with brain iron accumulation

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal intranuclear inclusion disease

next-generation sequencing

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

norepinephrine

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

opened mouth

ophthalmoplegia

optic atrophy

optokinetic nystagmus, abnormal

paraplegia, in flexion

parasomnia

paraspinal muscle

paraspinal muscle weakness

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, juvenile

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, on-off phenomena in

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

paroxysmal nonkinesigenic dyskinesia

pathologic reflex

patient information and support

penguin silhouette sign

penicillamine

personality change

phenothiazine

phenothiazine, dyskinesia associated with

phenylketonuria

Pick's disease

pigmentary retinopathy

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

POLG1 gene

polycythemia, secondary

pons, lesion of

postural abnormality

precipitating factors

primary familial brain calcification

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

propranolol

pseudobulbar palsy

pseudohypoparathyroidism

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

putamen, lesion of, bilateral

quadriplegia

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading problem, causes of

recurrent

Red flags

reflex sympathetic dystrophy

release phenomena

renal failure

repetition, impaired

respirations in CNS disease

restless leg syndrome

reversible neurologic disorder

saccadic eye movements, abnormal

salivation, excessive

scoliosis

seizure

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss

sensory loss, cortical

sensory tricks

sequencing difficulty

short stature

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

somnolence

spastic dysphonia

speech disorder

speech disorder, childhood

stimulation, deep brain

stimulation, thalamic

stooped posture

striatal encephalitis

striopallidodentate calcifications, familial idiopathic

subarachnoid hemorrhage

substantia nigra

suck reflex

swallow evaluation

symmetric brain lesions

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, lesion of-bilateral

torticollis, post traumatic

toxoplasmosis, CNS

trauma

treatment failure

treatment of neurologic disorder

tremor, post traumatic

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness, progressive

X-linked dystonia-parkinsonism syndrome

Showing articles 1150 to 1200 of 1676 << Previous Next >>

The Ethical Use of Human Fetal Tissue in Medicine
NEJM 320:1093-1096, Greely,H.T.,et al, 1989

The Politics of Transplantation of Human Fetal Tissue
NEJM 320:1079-1082, Annas,G.J.&Elias,S., 1989

Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989

Adrenal Medullary Transplantation to the Caudate Nucleus in Parkinson's Disease, Initial Results in 18 Patients
Arch Neurol 46:487-491, Allen,G.S.,et al, 1989

Adrenal Medullary Autografts in Patients with Parkinson's Disease
NEJM 321:324-327, Tanner,C.M.,et al, 1989

Clinical, Biochem, & Neuropath of Transplantation of Adrenal Medulla to Caudate Nucleus for Parkinson's
Neurol 39:1227-1234, Jankovic,J.,et al, 1989

Amount and Distribution of Dietary Protein Affects Clinical Response to Levodopa in Parkinson's Disease
Neurol 39:552-556, Carter,J.H., 1989

Influence of Fluctuations of Plasma Large Neutral Amino Acids with Normal Diets on the Clinical Response to Levodopa
JNNP 52:481-487, Nutt,J.G.,et al, 1989

The Effect of Dietary Protein on the Efficacy of L-Dopa:A Double-Blind Study
Neurol 39:549-552, Tsui,J.K.,et al, 1989

Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989

Psychiatric Aspects of Parkinson's Disease, Dementia, Depression, and Rarely Psychosis
BMJ 299:3-4, Baldwin,R.C.&Byrne,E.J., 1989

Effect of Age at Onset on Progression and Mortality in Parkinson's Disease
Neurol 39:1187-1190, Diamond,S.G.,et al, 1989

Diffuse Lewy Body Disease:Clinical Features in 15 Cases
JNNP 52:709-717, Byrne,E.J., 1989

The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989

Cortical Lewy Body Dementia:Clinical Features and Classification
JNNP 52:185-192, Gibb,W.R.G.,et al, 1989

Usefulness of a Writing Aid in Writer's Cramp
Neurol 39:149-150, Koller,W.C.&Vetere-Overfield,B., 1989

The"Yips":A Focal Dystonia of Golfers
Neurol 39:192-195, McDaniels,K.D.,et al, 1989

Treatment of Focal Dystonias of the Hand with Botulism Toxin Injections
JNNP 52:355-363, Cohen,L.G.,et al, 1989

Did Leonardo Describe Parkinson's Disease?
NEJM 320:593, Calne,D.B.,et al, 1989

Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989

The Olfactory and Cognitive Deficits of Parkinson's Disease:Evidence for Independence
Ann Neurol 25:166-171, Doty,R.L.,et al, 1989

Special Report of Fetal Tissue Transplants
National Right to Life News, January 22, 16:1-18989., , 1989

Multicenter Study of Autologous Adrenal Medullary Transplantation to Corpus Striatum in Pts with Advanced Parkinson's Dis
NEJM 320:337-341, Goetz,C.G.,et al, 1989

Autopsy Findings in a Patient Who Had an Adrenal-To-Brain Transplant for Parkinson's Disease
Neurol 39:235-238, Peterson,D.I.,et al, 1989

MR Imaging of Parkinson Disease with Spin-Echo and Gradient-Echo Sequences
AJR 152:159-165, Braffman,B.H.,et al, 1989

A Double-Blind Crossover Comparison of Sinemet CR4 and Standard Sinemet 25/100 in Patients with Parkinson's Disease
JNNP 52:207-212, Cedarbaum,J.M.,et al, 1989

Efficacy of Sinemet CR4 in Subgroups of Patients with Parkinson's Disease
JNNP 52:83-88, Factor,S.A.,et al, 1989

Frozen Shoulder and Other Shoulder Disturbances in Parkinson's Disease
JNNP 52:63-66, Riley,D.,et al, 1989

Acute Profound Dystonia in Infants with Glutaric Acidemia
Pediatrics 83:228-234, Bergman,I.,et al, 1989

Dystonic Posturing in Complex Partial Seizures of Temporal Lobe Onset:A New Lateralizing Sign
Neurol 39:196-201, Kotagal,P.,et al, 1989

Sleep Abnormalities in Progressive Supranuclear Palsy
Ann Neurol 25:577-581, Aldrich,M.S.,et al, 1989

Autologous Adrenal Medullary Transplant in Progressive Supranuclear Palsy
Neurol 39:1066-1068, Koller,W.C.,et al, 1989

MR Imaging in Progressive Suupranuclear Palsy and Shy-Drager Syndrome
J Comput Assist Tomogr 13:555-560, Savoiardo,M.,et al, 1989

Diltiazem-Induced Parkinsonism
Am J Med 87:95-96, Dick,R.S.&Barold,S.S., 1989

Risk Factors for Recurrent Nonsyncopal Falls, A Prospective Study
JAMA 261:2663-2668, Nevitt,M.C.,et al, 1989

Hemifacial Spasm Associated with Epidermoid Tumors of the Cerebellopontine Angle
Neurol 39:577-580, Auger,R.G.&Piepgras,D.G., 1989

Cyanide-Induced Parkinsonism:Clinical, MRI, and 6-Fluorodopa PET Studies
Neurol 39:142-144, Rosenberg,N.L.,et al, 1989

Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989

Dose-Dependent Memory Impairment in Parkinson's Disease
Neurol 39:438-440, Huber,S.J.,et al, 1989

Medical Problems of Musicians
NEJM 320:221-227, 246-2481989., Lockwood,A.H., 1989

Magnetic Resonance Imaging in Pathologically Proven Hallervorden-Spatz Disease
Neurol 39:440-442, Schaffert,D.A.,et al, 1989

Magnetic Resonance Imaging in Parkinson's Syndromes
Neurol 39:1524-1526, Stern,M.B.,et al, 1989

Magnetic Resonance Imaging in Dementia of Parkinson's Disease
JNNP 52:1221-1227, Huber,S.J.,et al, 1989

Tardive Oculogyric Crises
Neurol 39:1434-1437, FitzGerald,P.M.&Jankovic,J., 1989

Selegiline Use to Prevent Progression of Parkinson's Disease
Arch Neurol 46:1275-1279, Elizan,T.S.,et al, 1989

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group, NEJM 321:1364-13711989., , 1989

DATATOP:A Multicenter Controlled Clinical Trial in Early Parkinson's Disease
Parkinson Study Group, Arch Neurol 46:1052-10601989., , 1989

Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease
Arch Neurol 46:1280-1283, Elizan,T.S.,et al, 1989

Swallowing Abnormalities and Their Response to Treatment in Parkinson's Disease
Neurol 39:1309-1314, Bushman,M.,et al, 1989

Seizures in Progressive Supranuclear Palsy
Neurol 39:138-140, Nygaard,T.G.,et al, 1989

Showing articles 1150 to 1200 of 1676 << Previous Next >>